CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank50
5Y CAGR-65.2%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-65.2%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20250.38%
202434.64%
2023-352.22%
2022-2.27%
2021-41.94%
202073.62%
2019-543.40%
201812.77%
2017335.00%
2016-143.48%